Skip to main content
Clinical Trials/NCT06311097
NCT06311097
Recruiting
Not Applicable

Dairy Products to Your Gut and Brain

University of Copenhagen1 site in 1 country100 target enrollmentApril 8, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
University of Copenhagen
Enrollment
100
Locations
1
Primary Endpoint
Difference in change from baseline in defecation frequency between the interventions
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this intervention study is to compare the effects of fermented dairy and non-fermented dairy on bowel habits and cognitive performance in healthy women with defecations every other day or less. Furthermore, the study aims to explore underlying mechanisms linking the gut and the brain.

In addition, a sub-study will be conducted to explore differences in gut and brain measures between women with daily (reference group) and few (intervention group) weekly bowel movements, respectively, and to explore associations between measures of gut- and brain function.

Detailed Description

Participants in the intervention study (n=60) will consume 300g of fermented dairy (yogurt) or non-fermented dairy (milk) daily for 4 weeks. After a washout period of at least 4 weeks, the participants will consume the alternative dairy product (yogurt or milk) for 4 weeks. The participants will collect samples at home and be tested at the institute before and after each condition (yogurt or milk). Participants in the sub-study (n=40) will not undergo any dairy interventions and they will only take part in the baseline assessments. Prior to all visits at the institute, the participants are asked to complete some study activities at home, including: * consumption of sweet corns to estimate whole gut transit time * collection of fecal- and urine samples * measurement of methane and hydrogen in breath * reporting of gastrointestinal symptoms, including stool frequency and Bristol Stool Scale During all visits at the institute, the participants will undergo tests and measurements, including: * measurement of methane and hydrogen in fasting breath * collection of fasting blood samples * completion of cognitive tests * recordings of electrophysiological signals of the gut and the brain * completion of questionnaires assessing mood, quality of life, and physical activity, among others

Registry
clinicaltrials.gov
Start Date
April 8, 2024
End Date
September 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Henrik Munch Roager

Associate Professor

University of Copenhagen

Eligibility Criteria

Inclusion Criteria

  • Self-reported defecations every second day or less (intervention study only)
  • Willing to consume 300g milk/yogurt on a daily basis (intervention study only)
  • Owns a smartphone (iOS 11.0 and later or Android 5.0 and up)
  • Understand Danish or English

Exclusion Criteria

  • Current pregnancy or lactation
  • Dairy allergy or intolerance
  • Prior diagnosis of psychiatric or neurological illness
  • Current diagnosis of depression, anxiety, or stress
  • Prior diagnosis of metabolic or gastrointestinal disease (e.g., cardiovascular disease, diabetes, chronic constipation or diarrhea, inflammatory bowel diseases (IBD), celiac disease, small intestinal bacterial overgrowth (SIBO), cancer, etc.)
  • Use of antibiotics within the last month
  • Use of peroral corticosteroids (inhalers excepted)
  • Use of medications that alter normal bowel function and metabolism (e.g., laxatives, antidiarrheal agents, narcotics, diuretics, anticonvulsants, etc.)
  • Use of neuroactive medications (e.g., antidepressants, anxiolytics, anticonvulsants, antipsychotics, antiparkinsonian, etc.)
  • Concurrent participation in another trial

Outcomes

Primary Outcomes

Difference in change from baseline in defecation frequency between the interventions

Time Frame: Baseline and 4 weeks

Participants will report all bowel movements in a defecation diary in the week leading up to the intervention (baseline) and in the last week of the intervention (week 4)

Secondary Outcomes

  • Difference in change from baseline in phase-amplitude coupling between gastric slow-wave activity and cortical alpha activity between the interventions(Baseline and 4 weeks)
  • Difference in change from baseline in cognitive performance between the interventions(Baseline and 4 weeks)
  • Difference in change from baseline in self-reported gastrointestinal symptoms between the interventions(Baseline and 4 weeks)
  • Difference in change from baseline in stool consistency between the interventions(Baseline and 4 weeks)
  • Difference in change from baseline in fecal abundance of Lactobacillus acidophilus between the interventions(Baseline and 4 weeks)
  • Difference in change from baseline in whole gut transit time between the interventions(Baseline and 4 weeks)
  • Difference in change from baseline in stool moisture between the interventions(Baseline and 4 weeks)

Study Sites (1)

Loading locations...

Similar Trials